Navigation Links
Great Basin Scientific, Inc. Raises $3.6 Million in Bridge Funding to Prepare for Launch of First Product
Date:6/17/2009

d to begin in August.

Future tests beyond hospital-acquired infections (HAIs)

In addition to its first product for MRSA testing, the company is also developing tests for Group B Streptococcus - the most common cause of sepsis and meningitis in newborns, and Human Papilloma Virus (HPV), the most common sexually transmitted infection of which certain types can lead to cervical cancer.

Great Basin Scientific's technology has several advantages over the traditional Polymerase Chain Reaction (PCR) method that requires the skills of highly-trained technicians and often times multiple rooms to avoid cross contamination of tests. Its automated, highly-sensitive, easy-to-use integrated cartridge system can be performed in a CLIA-rated moderately complex or waived laboratory, and will give healthcare providers and their patients the benefit of point-of-care test results within a 20 - 60 minute time frame at costs much lower than current molecular solutions. Other benefits include the ability to test for 32 distinct targets in a single assay and no batching of tests required.

About Great Basin Scientific

Great Basin Scientific, Inc. is a privately held life sciences company that commercializes breakthrough technologies for the molecular, rapid diagnostic testing market. The company is dedicated to development of simple yet powerful point-of-care technology and products that improve automation, throughput, scalability, reliability and ease of use of rapid diagnostic testing for point-of-care settings such as physician's office labs, small-medium hospital labs and other moderately complex laboratory facilities.

The company was founded in 2003 by David Ward, Ph.D., deputy director of the Nevada Cancer Institute, formerly of Yale University of Medicine, and Anthony R. Torres, M.D., senior scientist and director of the Immunogenetics Laboratory, Uta
'/>"/>

SOURCE Great Basin Scientific, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
2. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
3. Newly Approved HIV Drug Shows Great Promise
4. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
5. BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
6. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
7. Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
8. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
9. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
10. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
11. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... and 300mg oral tablets, indicated for use in the ... Propafenone Hydrochloride 150mg, 225mg and 300mg tablets was $14 ... Arthur S. Przybyl , President and Chief Executive Officer ... our fourth product from the portfolio of approved generic ...
(Date:3/31/2015)... March 31, 2015  Oxis International, Inc. (OXIS) (OXI.PA) ... and commercialization, announced today Oxis CEO Tony Cataldo ... Oxis common shares on the Euronext exchange. Oxis shares ... symbol OXIS.   Oxis Chairman and CEO ... move forward with its strategies launched in 2014 and ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research ... announced the addition of the "North American ... Laboratory Information System), by Type (Clinical Pathology Laboratory ... Forecast to 2019" report to their offering. ... market is estimated to grow at a CAGR ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Oxis International Inc. Announces Request for Euronext Trading Suspension 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... of Senior Notes in Connection with... -- ARDEE, Ireland, Sept. 24 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... MSON ), a developer of state of ... used for acute health conditions, today announced plans to ... financial results on Tuesday, September 28, 2010.  Michael A. ... Senior VP and Chief Financial Officer, will host a ...
Cached Medicine Technology:Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 8Misonix Schedules Fourth Quarter and Fiscal 2010 Financial Results Conference Call; September 28, 2010 at 4:30 p.m. Eastern 2
(Date:3/31/2015)... (PRWEB) March 31, 2015 On November 24, ... All-Pro Lawrence Taylor to discuss the problem of substance abuse ... his own history of drug abuse and recovery, gives a ... Nicknamed “L.T.” by his teammates on the New York Giants, ... due to failed drug tests, yet he was able to ...
(Date:3/31/2015)... Angeles, CA (PRWEB) March 31, 2015 Dr. Parsa ... the pioneering hair transplant surgeons on the forefront of using ... A procedure once thought of, as a novelty has now become ... it comes to their hairlines. “I really do believe that beard ... a hair transplant if their donor area isn’t as dense as ...
(Date:3/31/2015)... Karen A. Daley, Ph.D. will address graduates ... Commencement ceremony on May 9, 2015 and will ... of her eminent career as a nurse, public health ... and senior staff nurse at Brigham and Women’s Hospital ... roles, including President of the American Nurses Association in ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Medical DNA ... has met all criteria for Laboratory Accreditation by COLA, ... only to laboratories that apply rigid standards of quality ... of proficiency testing, and pass a rigorous on-site laboratory ... accreditation as a result of a long-term commitment to ...
(Date:3/31/2015)... Los Angeles, CA (PRWEB) March 31, 2015 ... titled “Would You Go Down the Silicone Slope?” provides a ... , dermal filler , and laser treatments . ... an example) and reality TV stars such as Kim Kardashian ... and other social media are increasingly seen as significant influences ...
Breaking Medicine News(10 mins):Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2
... The following is a statement by Steve Millard , President & Executive Director, Council of Smaller Enterprises (COSE): , ... , , ... ... ...
... Joel A. Gingras, Jr. Award Presented to Joel A. Gingras, Jr. Memorial Fund , ... , , ... ... CHICAGO , March 12 The American Brain Tumor ...
... soon after diagnosis, , FRIDAY, March 12 (HealthDay News) -- ... months of diagnosis -- it appears the drug will remain ... suggests that to gain full benefit from metformin, patients should ... have diabetes," lead author Jonathan B. Brown, an investigator with ...
... ... web sites for his veterinary practice in Delray Beach and Boca Raton, Florida. These sites ... topics. , ... 2010 -- Palm Beach County veterinarian Dr. Arthur Malernee launched a new web site designed ...
... , ... , ... ... DALLAS , March 12 A new grassroots campaign is expected to generate ...
... operations for carcinoma of the rectum. Christian Schmidt et al. ... issue of Deutsches rzteblatt International ( Dtsch Arztebl ... more than 70,000 people develop colorectal carcinoma. The aim of ... on quality of life and sexual function. Data from 368 ...
Cached Medicine News:Health News:What Real Health Care Reform Must Address 2Health News:What Real Health Care Reform Must Address 3Health News:What Real Health Care Reform Must Address 4Health News:What Real Health Care Reform Must Address 5Health News:American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award 2Health News:American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award 3Health News:Start Metformin Early for Best Results 2Health News:Delray Beach and Boca Raton Veterinarian Launches New Web Sites for Atlantic Animal Hospital 2Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 2Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 3Health News:Think Tank & Radio Network Encourage Massive Resistance to ObamaCare 4
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
McIntyre lacrimal cannula, dual 0.3 mm side ports, straight....
Lacrimal cannula, malleable tip, straight....
Button Tip Manipulator, 0.50 mm diameter button tip, angled 45 degrees, 15 mm from tip to bend....
Medicine Products: